1. The NOP14 nucleolar protein suppresses the function and stemness of melanoma stem-like cells through Wnt/beta-catenin signaling inactivation
    Jingrong Li et al, 2022, Bioengineered CrossRef
  2. Establishment and characterization of a novel cancer stem‐like cell of cholangiocarcinoma
    Orasa Panawan et al, 2023, Cancer Science CrossRef
  3. MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen
    Richard E. Kast et al, 2022, Cancers CrossRef
  4. Drug Discovery in Liver Disease Using Kinome Profiling
    Bingting Yu et al, 2021, International Journal of Molecular Sciences CrossRef
  5. RAB6A functions as a critical modulator of the stem‐like subsets in cholangiocarcinoma
    Liangfang Yang et al, 2023, Molecular Carcinogenesis CrossRef
  6. Overexpression of KiSS1 Induces the Proliferation of Hepatocarcinoma and Increases Metastatic Potential by Increasing Migratory Ability and Angiogenic Capacity
    Cho-Won Kim et al, 2022, Molecules and Cells CrossRef
  7. HELLS modulates the stemness of intrahepatic cholangiocarcinoma through promoting senescence-associated secretory phenotype
    Xiaojing Du et al, 2023, Computational and Structural Biotechnology Journal CrossRef
  8. Single-cell RNA sequencing reveals cancer stem-like cells and dynamics in tumor microenvironment during cholangiocarcinoma progression
    Jihye L. Golino et al, 2023, Frontiers in Cell and Developmental Biology CrossRef
  9. Antitumor activity of T cells secreting αCD133-αCD3 bispecific T-cell engager against cholangiocarcinoma
    Thanich Sangsuwannukul et al, 2022, PLOS ONE CrossRef
  10. Immunotherapy for hepatobiliary cancers: Emerging targets and translational advances
    Dan Li et al, 2022, Hepatobiliary Cancers: Translational Advances and Molecular Medicine CrossRef
  11. Targeting key proteins involved in transcriptional regulation for cancer therapy: Current strategies and future prospective
    Haixiang Pei et al, 2022, Medicinal Research Reviews CrossRef
  12. Regulation of Hippo–YAP signaling axis by Isoalantolactone suppresses tumor progression in cholangiocarcinoma
    Cho-Long Kim et al, 2024, Translational Oncology CrossRef
  13. LOXL1-AS1 inhibits JAK2 ubiquitination and promotes cholangiocarcinoma progression through JAK2/STAT3 signaling
    Shaobo Yu et al, 2024, Cancer Gene Therapy CrossRef
  14. A live single-cell reporter system reveals drug-induced plasticity of a cancer stem cell-like population in cholangiocarcinoma
    Krittiyabhorn Kongtanawanich et al, 2024, Scientific Reports CrossRef
  15. FBXO31 sensitizes cancer stem cells‐like cells to cisplatin by promoting ferroptosis and facilitating proteasomal degradation of GPX4 in cholangiocarcinoma
    Zhiwen Zhu et al, 2022, Liver International CrossRef
  16. Characterization of Immunogenicity of Malignant Cells with Stemness in Intrahepatic Cholangiocarcinoma by Single-Cell RNA Sequencing
    Jing Bian et al, 2022, Stem Cells International CrossRef